Effects of propranolol on symptom and endocrine responses to pentagastrin

Psychoneuroendocrinology
Samir KhanJames L Abelson

Abstract

Intravenous injections of CCK-B agonists, such as pentagastrin, produce symptoms of panic and potent activation of the human hypothalamic-pituitary-adrenal (HPA) axis. It is unclear whether these psychological and endocrine effects are mediated by similar or independent processes. Independence is supported by prior evidence that beta-adrenergic receptor blockade attenuates cardiovascular and symptom but not vasopressin responses to CCK-4. To further explore associations between somatic, emotional and endocrine responses to CCK-B agents, and potential beta-adrenergic mediating mechanisms, symptom and endocrine responses to pentagastrin were examined after propranolol pre-treatment. Cardiovascular, symptom, and endocrine (ACTH, cortisol, epinephrine) responses to pentagastrin were measured in 16 healthy adult subjects randomly assigned to receive propranolol or placebo pre-treatment. Propranolol significantly blocked the normal cardiac acceleration produced by pentagastrin, but did not reduce panic symptom or anxiety effects. It delayed and perhaps enhanced the cortisol response. No relationship between HPA and symptom responses following pentagastrin could be detected, though pre-pentagastrin cortisol was inversely related to po...Continue Reading

References

Nov 1, 1992·Archives of General Psychiatry·A Y ShalevR K Pitman
Nov 1, 1992·Neuroendocrinology·J R GlowaE M Sternberg
Dec 1, 1991·Journal of Clinical Psychopharmacology·C L RavarisG J McHugo
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J HughesG N Woodruff
Jan 1, 1991·Annual Review of Pharmacology and Toxicology·G N Woodruff, J Hughes
Feb 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J BradwejnG Meterissian
Jan 1, 1989·The Journal of Clinical Endocrinology and Metabolism·N TomoriK Shizume
Feb 1, 1989·Archives of General Psychiatry·D J Nutt
Apr 1, 1987·Archives of General Psychiatry·S W WoodsG R Heninger
Feb 1, 1989·Archives of General Psychiatry·E HollanderD F Klein
Mar 1, 1986·The Journal of Nervous and Mental Disease·J W MasonL Podd
Jul 15, 1994·Biological Psychiatry·J L AbelsonA I Vinik
Jul 1, 1995·The American Journal of Psychiatry·R YehudaE L Giller
Feb 1, 1995·Journal of Abnormal Psychology·S P OrrR K Pitman
Mar 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·U D McCannT W Uhde
Jul 3, 1998·European Journal of Applied Physiology and Occupational Physiology·R OberbeckM Schedlowski
Sep 11, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J L Abelson, I Liberzon
Jul 6, 2000·Journal of Thermal Biology·M SimeckováP Srámek
Dec 20, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J L AbelsonD G Bichet

❮ Previous
Next ❯

Citations

Jul 1, 2009·Journal of Chemical Neuroanatomy·Thelma A Lovick
May 4, 2012·Depression and Anxiety·P ZwanzgerJ Bradwejn
Aug 30, 2005·Anais Da Academia Brasileira De Ciências·Frederico G GraeffFrancisco S Guimarães
Apr 24, 2007·Psychopharmacology·Jorge Perez-ParadaJean-Michel Le Mellédo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.